Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Haupt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Journal of Clinical and Experimental Urology|November 26, 2019
Humanized mice for immune checkpoint blockade in human solid tumorsHenry Yip, Carl Haupt, Grace Maresh, et al.
Oncotarget|September 8, 2018
Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cellsChristian Schütz, Juan Carlos Varela, Karlo Perica, et al.
Oncotarget|September 8, 2016
Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cellsChristian Schütz, Juan Carlos Varela, Karlo Perica, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2015
CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting CellsHeiko Bruns, Catherine Bessell, Juan Carlos Varela, et al.
Cancers|May 27, 2026
Optimizing Sequential Targeted Therapies in Advanced Renal Cell Carcinoma Using Patient-Derived Orthotopic Xenograft Mouse AvatarsAmita Bhattarai, Ravan Moret, Xin Zhang, et al.
Journal of Immunology Research and Therapy|August 22, 2017
The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer ImmunotherapiesLillian R Neal, Stefanie R Bailey, Megan M Wyatt, et al.
The Journal of Clinical Investigation|December 3, 2013
Sprouty-2 regulates HIV-specific T cell polyfunctionalityYen-Ling Chiu, Liang Shan, Hailiang Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 27, 2025
The Translational Research Program in Cancer Differences across PopulationsJane C Figueiredo, Diana Redwood, Li Li, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Journal of Clinical and Experimental Urology|November 26, 2019
Humanized mice for immune checkpoint blockade in human solid tumorsHenry Yip, Carl Haupt, Grace Maresh, et al.
Oncotarget|September 8, 2018
Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cellsChristian Schütz, Juan Carlos Varela, Karlo Perica, et al.
Oncotarget|September 8, 2016
Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cellsChristian Schütz, Juan Carlos Varela, Karlo Perica, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2015
CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting CellsHeiko Bruns, Catherine Bessell, Juan Carlos Varela, et al.
Cancers|May 27, 2026
Optimizing Sequential Targeted Therapies in Advanced Renal Cell Carcinoma Using Patient-Derived Orthotopic Xenograft Mouse AvatarsAmita Bhattarai, Ravan Moret, Xin Zhang, et al.
Journal of Immunology Research and Therapy|August 22, 2017
The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer ImmunotherapiesLillian R Neal, Stefanie R Bailey, Megan M Wyatt, et al.
The Journal of Clinical Investigation|December 3, 2013
Sprouty-2 regulates HIV-specific T cell polyfunctionalityYen-Ling Chiu, Liang Shan, Hailiang Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 27, 2025
The Translational Research Program in Cancer Differences across PopulationsJane C Figueiredo, Diana Redwood, Li Li, et al.
Pageof 1